U.S. Personal Products Stock News

The Hanover Insurance Group (THG) just grabbed attention with a fresh Market Outperform rating, solid second-quarter results, a $500 million notes offering, and a leadership appointment in its technology and life sciences business. See our latest analysis for Hanover Insurance Group. Hanover Insurance’s latest moves come on top of a solid year for investors. The stock’s total shareholder return reached 12.7% over the last twelve months and 38% over three years. Momentum is building as renewed...

Dynavax Technologies (DVAX) has seen some movement in its share price recently, and many investors are taking a closer look at what is driving changes over the past month. While the broader biotech sector can be volatile, Dynavax continues to attract curiosity as it works to grow its revenue base and manage financial performance. See our latest analysis for Dynavax Technologies. Dynavax Technologies has seen some ups and downs, with a 2.72% 1-month share price return hinting at renewed...

Thinking about Mister Car Wash stock and not sure whether to buy, hold, or move on? You’re not alone. After all, shares closed recently at $4.79, and it’s no surprise many investors are trying to make sense of what’s next. On one hand, the stock has clawed back 1.5% in the last week, raising eyebrows among short-term traders. On the other hand, Mister Car Wash is still down more than 34% year-to-date and off 41.4% over the past three years, which has put a cloud over its shine. That kind of...

Trip.com Group (NasdaqGS:TCOM) put the spotlight on its AI travel assistant, TripGenie, during ITB Asia 2025. The company shared how the platform's success in boosting user engagement and bookings is shaping the expansion of its travel services. See our latest analysis for Trip.com Group. Trip.com Group’s announcement about enhanced AI-driven travel experiences comes as momentum is building in its stock, which has delivered a 15% total shareholder return over the past year and an impressive...

Spyre Therapeutics, Inc. just completed and priced a major underwritten public offering, bringing in over $275 million through common stock and pre-funded warrants. This move immediately boosts their cash reserves for pipeline development. See our latest analysis for Spyre Therapeutics. In the wake of Spyre Therapeutics’ successful capital raise, recent momentum has been remarkable, with a 30-day share price return of 49.3% and a 7-day jump of 17.4%. While the stock still faces a one-year...

Krystal Biotech (KRYS) stock is drawing attention after the company announced that the FDA granted platform technology designation to its viral vector used in the KB801 gene therapy eye drop. This regulatory step may help streamline future drug development and review processes for Krystal's pipeline therapies. See our latest analysis for Krystal Biotech. On the heels of the FDA’s platform technology designation, Krystal Biotech’s share price has climbed more than 23% over the past month,...

Thinking about what’s next for Tesla stock? You’re not alone. After a remarkable 99.1% climb over the last year and another 15.8% jump year-to-date, the big question on everyone’s mind is whether there’s more runway or if it’s time to re-evaluate. Recent headlines have been anything but quiet. Whisperings about White House efforts to ease auto industry tariffs briefly lifted the entire sector, and Tesla certainly enjoyed a 6.2% lift this past week. Still, big headlines like the ISS pushback...

Adams Diversified Equity Fund, Inc. recently reported a 16.0% total return on net asset value for the first nine months of 2025, with a total market price return of 17.8% for the period. The fund’s performance notably surpassed several relevant benchmarks, highlighting its recent track record for investors ahead of the upcoming Third Quarter Report to Shareholders expected on October 22, 2025. We'll explore how the announcement of outsized investment returns shapes the Adams Diversified...

Main Street Capital recently announced the completion of an US$81 million portfolio investment to support the minority recapitalization of a musculoskeletal care management services organization in the Southeastern U.S., alongside preliminary third-quarter 2025 results showing record net asset value per share and robust return on equity. This combination of a sizable new investment and ongoing financial performance highlights Main Street Capital's continued deployment of capital into growth...

Mattel (MAT) and Roblox's expanded partnership is stirring up conversation, as the two companies gear up to release a lineup of new digital games spotlighting Mattel's signature brands, including Monster High and Barbie. This collaboration is designed to translate brand success from shelves to screens, with a focus on building ongoing digital engagement and future growth. See our latest analysis for Mattel. Mattel’s latest string of collaborations, including its expanded partnership with...

Commvault Systems recently received multiple analyst upgrades, including ratings changes by Piper Sandler and Guggenheim, citing optimism about the company's positioning ahead of its November SHIFT event. Despite this strengthening analyst sentiment, there has been significant insider selling activity over the past six months, highlighting some ongoing market caution even as further company developments are anticipated. We'll explore how growing analyst optimism around the upcoming SHIFT...

In recent days, CleanSpark (CLSK.US) saw heightened options activity, with calls making up nearly 79% of trades and a significant put option position taken with an $8.50 strike expiring in October 2025. This surge in derivative trading reflects growing institutional attention to Bitcoin miners, supported by CleanSpark's comments highlighting increased ETF inflows, credit market development, and broader acceptance of Bitcoin as a financial asset class. With institutional adoption...

Regal Rexnord (RRX) recently landed in the spotlight as challenges with its core business and decreasing earnings per share caught investors’ attention. This has sparked questions about the company’s growth plans and long-term outlook. See our latest analysis for Regal Rexnord. Regal Rexnord’s share price has lost ground this year, reflecting weaker sentiment as investors digest declining core performance and softer earnings. The 1-year total shareholder return stands at -19.9%. Despite...

ANI Pharmaceuticals recently announced that results from the NEW DAY clinical trial of ILUVIEN for diabetic macular edema were presented in a late-breaking oral session at the American Academy of Ophthalmology 2025 meeting. This spotlight on ILUVIEN's clinical and safety profile highlights both the drug's market potential and the importance of monitoring risks such as intraocular pressure and cataract development in real-world use. We'll explore how this heightened clinical focus on...

If you have been watching Alphabet's stock lately, you are not alone. It is the kind of company people talk about at dinner, and with good reason. Many investors are wondering whether now is the right time to hold, buy, or cash in on those hefty gains. The past year especially has been more than just solid, with Alphabet chalking up a 55.7% return over twelve months and an impressive 152.2% over three years. Year to date, it is up 33.7%, which certainly turns heads, and the last week alone...

Natera (NTRA) just landed on Fast Company’s 2025 Next Big Things in Tech list, recognized for its Signatera molecular residual disease test for cancer. This type of industry validation sometimes sparks renewed interest in growth stocks in biotech. See our latest analysis for Natera. After getting recognized for its Signatera test and presenting at this year’s ESMO Congress, Natera has caught investor attention with a 7% share price gain this past week alone. The stock’s one-year total...

In recent weeks, EMCOR Group has attracted favorable analyst sentiment and reported increased earnings estimates, with multiple firms reiterating or raising their positive outlooks on the company’s performance potential. Analysts point to EMCOR’s strong operational performance, including upgraded earnings forecasts, a history of positive earnings surprises, and momentum in high-demand sectors, as key contributors to the heightened optimism. We’ll explore how the positive revisions to...

On October 13th, Brookfield Asset Management and Bloom Energy announced a partnership in which Brookfield will invest up to US$5 billion to deploy Bloom's fuel cell technology for the development of AI factories worldwide. This collaboration highlights a shift toward integrating advanced, on-site clean energy solutions to address the massive and growing power needs driven by artificial intelligence infrastructure. We'll explore how Brookfield's multibillion-dollar commitment to fuel...

HF Sinclair (DINO) caught investors’ eyes following its latest quarterly update. The company’s strong refining throughput, lower operating costs, and substantial return of capital to shareholders are at the core of recent activity around the stock. See our latest analysis for HF Sinclair. Shares of HF Sinclair reflect this recent momentum, climbing 18% over the past 90 days with a year-to-date share price return approaching 48%. The company’s progress on capturing operational efficiencies and...

Soluna Holdings (SLNH) just closed a $100 million credit facility from Generate Capital, aiming to expand its green data center footprint. With past financing hurdles settled and fresh partnerships on board, the stage is set for potential growth. See our latest analysis for Soluna Holdings. After months of volatility, Soluna Holdings’ momentum has shifted dramatically. Its 30-day share price return surged 348.73%, with a 7-day jump of 83.40% to $4.42 following news of new credit facilities...

Array Technologies, Inc. announced it will release its third quarter 2025 results after the market closes on November 5, followed by a conference call for investors that same evening. This event comes as analysts and investors increasingly focus on the company’s recent acquisition of APA Solar and ongoing product launches, which are viewed as significant drivers of its future performance. To explore how these company developments, especially the APA Solar acquisition, impact Array...

Earlier this week, Check Point Software Technologies was recognized by Fast Company’s Next Big Things in Tech 2025 list for its pioneering work in proactive blockchain threat prevention, including real-time capabilities active on the Cardano mainnet. This recognition highlights Check Point’s shift from reactive cybersecurity to advanced, in-chain protection for decentralized ecosystems, positioning the company as an innovator against evolving online threats. We will examine how this industry...

So, you’re wondering what to do with Ambarella’s stock after its recent run. Maybe you’ve noticed the 41.9% surge over the past year, or the solid 13.4% jump just in the last week. Long-term holders have done alright too, with a 52.9% gain over three years and 44.7% over five. Clearly, momentum has returned in a big way. This is not just because of general market buzz. Tech-focused investors are re-evaluating image processing and AI hardware companies, with Ambarella benefiting from...

Zebra Technologies (ZBRA) shares have navigated some ups and downs lately, as investors weigh its recent performance against broader tech sector trends. The company’s stock has slipped nearly 8% over the past month. See our latest analysis for Zebra Technologies. While Zebra Technologies’ share price return has stumbled over the past year, down more than 20% on a total shareholder return basis, momentum has been mixed lately, with a bounce last week but a more challenging run over the past...